GLUTAMICS—a randomized clinical trial on glutamate infusion in 861 patients undergoing surgery for acute coronary syndrome  Mårten Vidlund, MD, PhD, Erik.

Slides:



Advertisements
Similar presentations
Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Advertisements

Manuel J. Antunes, MD, PhD, DSc 
Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,
A wolf in sheep's clothing
Amiodarone after surgical ablation for atrial fibrillation: Is it really necessary? A prospective randomized controlled trial  Niv Ad, MD, Sari D. Holmes,
Randomized controlled trial of brief cognitive behavioral intervention for depression and anxiety symptoms preoperatively in patients undergoing coronary.
Personalized cardiac surgery: Can noninvasive flow imaging lead to individualized resection strategies for bicuspid aortopathy?  Nicholas D. Andersen,
Intrinsic cardiac stem cells are essential for regeneration
Juan A. Crestanello, MD, Richard C. Daly, MD 
Defining operative mortality: Impact on outcome reporting
William M. DeCampli, MD, PhD 
Multilevel data analysis: What? Why? How?
Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all  David Faraoni, MD,
Go on-pump or off-pump in diabetic patients?
Harold L. Lazar, MD  The Journal of Thoracic and Cardiovascular Surgery 
Resuscitation practices in cardiac surgery
Shawn S. Groth, MD, Bryan M. Burt, MD 
One-year results of thoracic endovascular aortic repair for blunt thoracic aortic injury (RESCUE trial)  Ali Khoynezhad, MD, PhD, FACS, Carlos E. Donayre,
The lord of the rings  Antonio Miceli, MD, PhD 
Certification in cardiothoracic surgical critical care: A distinction for some or for all?  Nicholas D. Andersen, MD  The Journal of Thoracic and Cardiovascular.
Igor E. Konstantinov, MD, PhD, FRACS 
In type A aortic dissection repair, an effective team approach and relational coordination are more important for patients' outcomes than surgeon volume 
Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model  Daniel.
Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology  Juan A. Crestanello, MD  The Journal of.
Intra-aortic balloon pumps and continuous flow left ventricular assist devices: Don't let balloon pumps overstay their welcome  Kevin G. Soucy, PhD, Steven.
Juan N. Pulido, MD  The Journal of Thoracic and Cardiovascular Surgery 
Left ventricular assist device therapy in a patient with hearing and speech disabilities  Sotirios Spiliopoulos, MD, PhD, Vera Hergesell, MD, Otto Dapunt,
Innovation and science: The future of valve design
It's not “just a shunt” but sometimes it should be…
Michele Gallo, MD, Gino Gerosa, MD 
A first start for lung transplantation?
Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem?  Francis D. Pagani, MD, PhD  The Journal.
Niv Ad, MD, Sari D. Holmes, PhD, Paul S. Massimiano, MD, Anthony J
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
A randomized comparison of different ventilator strategies during thoracotomy for pulmonary resection  Andrew D. Maslow, MD, Todd S. Stafford, MD, Kristopher.
Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass  Benjamin Medalion, MD, Michael G. Katz, MD,
Transient right ventricular dysfunction caused by retractor during lower hemisternotomy mitral valve repair in a patient with pectus excavatum  Homare.
Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD 
Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc 
Leora B. Balsam, MD, Abe DeAnda, MD 
Niv Ad, MD, Lawrence M. Wei, MD 
Left sinus of Valsalva aneurysm: Rare disease, rarer presentation
Instrumental variable methods in clinical research
Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD 
Case reporter's notebook: The who, what, when, where, how, and why of extraction of a benign intracaval tumor  Verdi J. DiSesa, MD, MBA  The Journal of.
Marc Licker, MD, John Diaper, RA 
The Ross procedure: Time to reevaluate the guidelines
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes  Sitaram M. Emani, MD  The Journal of Thoracic.
Ralph S. Mosca, MD  The Journal of Thoracic and Cardiovascular Surgery 
Bryan M. Burt, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Ventricular assistant in restrictive cardiomyopathy: Making the right connection  Robert D.B. Jaquiss, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids  Paul.
“The more things change…”: The challenges ahead
Toward a more rational approach in treating type B aortic dissection
Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know  Harold L. Lazar,
Ryan R. Davies, MD  The Journal of Thoracic and Cardiovascular Surgery 
Apples remain apples NO matter what
Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery  Raja M. Flores, MD  The Journal.
A large international single-center case-series of coronary artery fistulas in children: When high clinical research standards adopted globally create.
The evolution of cardiothoracic critical care
Sunjay Kaushal, MD, PhD, Brody Wehman, MD 
Did you like Terminator 3 better than Terminator 2
A good chimney requires a good sweep
How do we follow up our patients
Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”
Deciding how much to pay for effective care
Presentation transcript:

GLUTAMICS—a randomized clinical trial on glutamate infusion in 861 patients undergoing surgery for acute coronary syndrome  Mårten Vidlund, MD, PhD, Erik Håkanson, MD, PhD, Örjan Friberg, MD, PhD, Sören Juhl-Andersen, MD, Jonas Holm, MD, Farkas Vanky, MD, PhD, Lena Sunnermalm, MD, Jan-Olov Borg, MD, Rajiv Sharma, MD, Rolf Svedjeholm, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 144, Issue 4, Pages 922-930.e7 (October 2012) DOI: 10.1016/j.jtcvs.2012.05.066 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Consort flow chart. The Journal of Thoracic and Cardiovascular Surgery 2012 144, 922-930.e7DOI: (10.1016/j.jtcvs.2012.05.066) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure E1 Duration of (A) intensive care unit (ICU) stay and (B) ventilator treatment in patients with left ventricular failure at weaning from cardiopulmonary bypass in the glutamate group (n = 20) or control group (n = 18). LV, Left ventricular; CPB, cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery 2012 144, 922-930.e7DOI: (10.1016/j.jtcvs.2012.05.066) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions